Myanmar introduced HPV vaccination in 2020 targeting 9-year-old girls but faced program interruptions in 2021–2022 due to instability and supply shortages. In 2023, the program resumed with a catch-up campaign, shifting from a two-dose to a single-dose schedule aligned with WHO recommendations. Delivery combined school-based and community approaches, supported by the Vaccine Management Information System […]
Country: Myanmar
Decision-making to switch to single dose
The presentation outlines Myanmar’s policy shift from a two-dose to a single-dose HPV vaccination schedule, driven by operational challenges during COVID-19, missed cohorts, and WHO’s updated recommendations. NITAG adopted a systematic, evidence-based approach using PICO criteria to guide decision-making, ensuring transparency and technical rigor. The revised strategy targets 9–11-year-old girls through school and community campaigns, […]
Overview of Human Papilloma Virus (HPV) Vaccine introduction in Myanmar
The poster presents Myanmar’s HPV vaccination program, initiated in 2020 targeting girls aged 9–11 years, with a national administrative coverage of 88% in 2023. It highlights the shift from a two-dose to a single-dose schedule, aligned with WHO recommendations, aiming to improve efficiency and coverage. Key strategies include school-based and community outreach phases, leveraging digital […]
Country Snapshots – Myanmar
Myanmar’s HPV vaccination program, launched in 2020, transitioned from a two‑dose to a single‑dose schedule in August 2023 following SAGE and NITAG guidance. National coverage reached 90% in 2020 and 88% in 2023, with over 970,000 girls vaccinated. The program targets 9–11‑year‑old girls, including missed cohorts, using school‑ and community‑based strategies supported by the Vaccine […]